Events
The Monthly Summary of Training Programs Conducted by the Egyptian Drug Authority (EDA)
01 September 2025
-
30 September 2025
| EDA concludes a workshop on Nitrosamine Impurities in collaboration with the United States Pharmacopeia (USP) EDA concludes a training program on Models and Approaches of Change Management to Enhance Institutional Competencies EDA concludes an advanced training program on Operational Procedures and Regulatory Licensing for Pharmaceutical and Medical Device Manufacturing Plants EDA concludes a workshop on Common Deficiencies in Stability Studies Submitted to the Authority EDA concludes a discussion session on the Draft Updates of the International Guideline ICH M4Q(R2) ....................................................... As part of the #Egyptian_Drug_Authority’s commitment to enhancing the competencies of human resources in the pharmaceutical sector through high-quality training programs designed by the Continuous Professional Development Center, and in recognition of its vital role in providing technical support, maintaining direct communication with industry partners, supporting institutional excellence programs for EDA employees, and promoting pharmaceutical awareness through specialized training programs— The Egyptian Drug Authority (EDA) announced the conclusion of a workshop on Nitrosamine Impurities, held in collaboration with the United States Pharmacopeia (USP), with the participation of American expert Naiffer Romero. Additionally, the training program titled “Models and Approaches of Change Management” was successfully completed, in cooperation with a multinational company. The Authority also concluded an advanced training program on operational procedures, regulatory guidelines, and licensing requirements for pharmaceutical and medical device manufacturing plants, as part of its role in ensuring the implementation of Good Manufacturing Practices (GMP) and issuing technical operational licenses, in collaboration with the Industrial Development Authority. Furthermore, EDA completed a workshop on common deficiencies in stability studies submitted to the Authority, with the participation of trainees representing pharmaceutical companies and stability centers. The Authority also concluded a discussion session dedicated to reviewing the draft updates of the international guideline ICH M4Q(R2), issued by the International Council for Harmonisation (ICH), which sets forth global standards for organizing, structuring, and submitting dossiers to regulatory authorities. It is noteworthy that the total number of trainees who participated in the training programs and workshops reached 285 participants from various entities within the pharmaceutical sector. These activities come within the framework of the Egyptian Drug Authority’s ambitious plan to enhance the professional level of all personnel across the pharmaceutical fields, familiarize them with the latest developments in all related areas, and build qualified human capacities capable of achieving development and institutional excellence. This also supports cooperation with the private sector in line with the strategic goals of sustainable development under “Egypt Vision 2030.” |
Tags
Egyptian Drug Authority
Monthly Summary